All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Stanford University Dr. Judith A Shizuru Disease Team Therapy Development – Research A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $18,990,683
University of California, Davis Dr. John Laird Disease Team Therapy Development – Research Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia $3,728,384
University of California, Davis Dr. Vicki Wheelock Disease Team Therapy Development – Research MSC engineered to produce BDNF for the treatment of Huntington’s disease $8,924,235
StemCells, Inc. Dr. Nobuko Uchida Disease Team Therapy Development – Research Neural stem cell transplantation for chronic cervical spinal cord injury $0
University of California, Davis Nancy E. Lane Disease Team Therapy Development – Research Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells $18,227,898
Salk Institute for Biological Studies Dr. David R Schubert Early Translational III Stem cell based small molecule therapy for Alzheimer’s disease $1,673,757
City of Hope, Beckman Research Institute Dr. Stephen J Forman Early Translational III Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells $5,215,447
Gladstone Institutes, J. David Dr. Deepak Srivastava Early Translational III Direct Cardiac Reprogramming for Heart Regeneration $5,795,871
University of California, San Diego Dr. Lawrence S. B. Goldstein Early Translational III Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells $1,774,420
University of California, San Diego Dr. Yang Xu Early Translational III Human ES cell based therapy of heart failure without allogenic immune rejection $1,857,600
Stanford University Dr. Joseph C. Wu Early Translational III Heart Repair with Human Tissue Engineered Myocardium $4,395,080
University of California, San Francisco Mort Cowan Early Translational III Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID $3,862,367
Stanford University Professor Helen M. Blau PhD Early Translational III Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,283
University of Southern California Dr. Toshio Miki Early Translational III Generation of hepatic cell from placental stem cell for congenital metabolic disorders $1,750,375
Children’s Hospital of Orange County Dr. Philip H Schwartz Early Translational III Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease $4,266,015
University of California, San Francisco Dr. Holger F Willenbring Early Translational III Generation of safe and therapeutically effective human induced hepatocyte-like cells $1,544,170
Salk Institute for Biological Studies Juan Carlos Izpisua Belmonte Early Translational III Direct reprogramming towards vascular progenitors for the treatment of ischemia $2,340,000
University of California, San Diego Dr. Eric D. Adler MD Early Translational III Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease $1,701,575
University of California, Davis Walter Douglas Boyd Early Translational III Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair $4,631,754
Stanford University Dr. Bertha Chen Early Translational III Autologous iPSC Therapy for Urinary Incontinence $4,715,738
University of California, San Diego Mark Tuszynski Early Translational III Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury $4,600,447
University of California, Davis Prof. Kyriacos A. Athanasiou Ph.D Early Translational III Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells $1,735,703
University of California, Irvine Craig M. Walsh Early Translational III Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells $4,535,005
Scripps Research Institute Peter G. Schultz Early Translational III Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis $2,559,333
University of California, San Francisco Dr. Arnold Kriegstein Early Translational III Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury $1,623,251
University of California, San Diego Gene Wei-Ming Yeo Early Translational III Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons $1,532,323
University of California, Santa Cruz Dr. David Haussler Training Grant I-3 Training Program in Systems Biology of Stem Cells $1,133,701
University of California, Santa Barbara Dr. Dennis O. Clegg Training Grant I-3 UCSB Stem Cell Biology Training Program $975,334
Salk Institute for Biological Studies Juan Carlos Izpisua Belmonte Training Grant I-3 Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies $1,261,333
California Institute of Technology Paul H. Patterson Training Grant I-2 Training in Stem Cell Biology at CIT $1,817,214
Children’s Hospital of Los Angeles Dr. Donald B. Kohn Training Grant I-2 Training Grant 1 $2,173,872
Sanford Burnham Prebys Medical Discovery Institute Dr. Mark Mercola Training Grant I-2 Burnham Institute CIRM Stem Cell Training Grant (Type II) $1,061,865
Gladstone Institutes, J. David Dr. Robert W Mahley Training Grant I-2 Gladstone CIRM Scholar Program $2,192,073
Scripps Research Institute Peter G. Schultz Training Grant I-2 Training Grant I $1,021,395
University of California, Davis Dr. Frederick J Meyers MD Training Grant I-1 Stem Cell Research Training Grant $1,780,859
University of California, San Francisco Dr. Susan J Fisher PhD Training Grant I-1 Training Grant I $2,868,145
University of California, Los Angeles Dr. Owen N Witte M.D. Training Grant I-1 CIRM Type I Comprehensive Training Program $3,660,398
University of Southern California Dr. Robert E Maxson Training Grant I-1 CIRM Stem Cell Biology Training Grant $2,332,431
University of California, Irvine Dr. Peter Bryant Training Grant I-1 Stem Cell Research Training Grant $1,935,487
University of California, Berkeley Randy W. Schekman Training Grant I-1 Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland $2,360,457
University of California, San Diego Dr. Lawrence S. B. Goldstein Training Grant I-1 Interdisciplinary Stem Cell Training Program at UCSD $3,459,396
Stanford University Michael T. Longaker M.D. Training Grant I-1 Stanford CIRM Training Program $3,035,282
University of California, Davis Dr Mehrdad Abedi Disease Team Therapy Planning I Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients $66,880
University of California, Davis Dr. John Laird Disease Team Therapy Planning I Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia $76,066
University of California, Davis Dr. Vicki Wheelock Disease Team Therapy Planning I MSC engineered to produce BDNF for the treatment of Huntington’s disease $97,564
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Planning I Stem Cells Secreting GDNF for the Treatment of ALS $63,487
Stanford University Dr. Albert J Wong Disease Team Therapy Planning I Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Stanford University Dr. Judith A Shizuru Disease Team Therapy Planning I A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
OncoMed Pharmaceuticals, Inc. Timothy Hoey Disease Team Therapy Planning I Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency $65,120
Cedars-Sinai Medical Center Dr. Dan Gazit Disease Team Therapy Planning I Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. $107,622